{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:33:05Z","timestamp":1694629985589},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s11899-007-0002-6","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T14:29:54Z","timestamp":1176906594000},"page":"9-12","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mixed myeloproliferative and myelodysplastic disorders"],"prefix":"10.1007","volume":"2","author":[{"given":"Peter D.","family":"Emanuel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,15]]},"reference":[{"key":"2_CR1","first-page":"61","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours","author":"R.D. Brunning","year":"2001","unstructured":"Brunning RD, Bennett JM, Flandrin G, et al.: Myelodysplastic syndromes. In Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours. Edited by Jaffe ES, Harris NL, Stein H, Vardimann JW. Lyon, France: IARC Press; 2001:61\u201373."},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P. Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, et al.: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079\u20132088.","journal-title":"Blood"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","volume":"87","author":"J.M. Bennett","year":"1994","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al.: The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic leukemia, atypical chronic myeloid and chronic myelomonocytic leukemia: proposals by the French-American-British Cooperative Leukemia Group. Br J Haematol 1994, 87:746\u2013754.","journal-title":"Br J Haematol"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0145-2126(00)00159-4","volume":"25","author":"J. Voglova","year":"2001","unstructured":"Voglova J, Chrobak L, Neuwirtova R, et al.: Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia\u2014distinct subgroups or two stages of the same disease?\n                           Leuk Res 2001, 25:493\u2013499.","journal-title":"Leuk Res"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.beha.2005.07.001","volume":"19","author":"A. Tefferi","year":"2006","unstructured":"Tefferi A, Gilliland G: Classification of chronic myeloid disorders: from Dameshek towards a semi-molecular system. Best Pract Res Clin Haematol 2006, 19:365\u2013385.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"2_CR6","first-page":"1","volume":"2","author":"P. Emanuel","year":"2005","unstructured":"Emanuel P, Prchal JT: The molecular basis of polycythemia vera unraveled?\n                           The Hematologist: ASH News and Reports 2005, 2(3):1\u20132.","journal-title":"The Hematologist: ASH News and Reports"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","volume":"77","author":"T.R. Golub","year":"1994","unstructured":"Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994, 77:307\u2013316.","journal-title":"Cell"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1182\/blood.V99.3.840","volume":"99","author":"F. Onida","year":"2002","unstructured":"Onida F, Kantarjian HM, Smith TL, et al.: Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002, 99:840\u2013849.","journal-title":"Blood"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1200\/JCO.2002.04.117","volume":"20","author":"L.R. Silverman","year":"2002","unstructured":"Silverman LR, Demakos EP, Peterson BL, et al.: Randomized controlled trial of azacitidine in patients with myelodysplastic syndrome: a study of the CALGB. J Clin Oncol 2002, 20:2429\u20132440.","journal-title":"J Clin Oncol"},{"key":"2_CR10","first-page":"1774","volume":"106","author":"H. Kantarjian","year":"2006","unstructured":"Kantarjian H, Issa JP, Rosenfeld CS, et al.: Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 2006, 106:1774\u20131780.","journal-title":"Cancer"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1158\/1078-0432.CCR-04-2135","volume":"11","author":"E. Kaminskas","year":"2005","unstructured":"Kaminskas E, Farrell A, Abraham S, et al.: Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes. Clin Cancer Res 2005, 11:3604\u20133608.","journal-title":"Clin Cancer Res"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/sj.bmt.1705369","volume":"37","author":"M.A. Elliott","year":"2006","unstructured":"Elliott MA, Tefferi A, Hogan WJ, et al.: Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia. Bone Marrow Trans 2006, 37:1003\u20131008.","journal-title":"Bone Marrow Trans"},{"key":"2_CR13","doi-asserted-by":"crossref","unstructured":"Kantarjian H, Oki Y, Garcia-Manero G, et al.: Results of a randomized study of three schedules of low-dose decitabine in higher risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 2006, In press.","DOI":"10.1182\/blood-2006-05-021162"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood.V91.1.365","volume":"91","author":"D. Pinkel","year":"1998","unstructured":"Pinkel D: Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1998, 91:365\u2013367.","journal-title":"Blood"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","volume":"105","author":"F. Locatelli","year":"2005","unstructured":"Locatelli F, Noelke P, Zecca M, et al.: Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOGMDS\/EBMT trial. Blood 2005, 105:410\u2013419.","journal-title":"Blood"},{"key":"2_CR16","first-page":"203","volume":"3","author":"P.D. Emanuel","year":"2004","unstructured":"Emanuel PD: Juvenile myelomonocytic leukemia [review]. Curr Hematol Rep 2004, 3:203\u2013209.","journal-title":"Curr Hematol Rep"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ng0296-137","volume":"12","author":"D.A. Largaespada","year":"1996","unstructured":"Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: Nf1 deficiency causes Ras-mediated granulocyte\/macrophage colony-stimulating factor hypersensitivity and chronic myeloid leucemia. Nat Genet 1996, 12:137\u2013143.","journal-title":"Nat Genet"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ng0296-144","volume":"12","author":"G. Bollag","year":"1996","unstructured":"Bollag G, Clapp DW, Shih S, et al.: Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in hematopoietic cells. Nat Genet 1996, 12:144\u2013148.","journal-title":"Nat Genet"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1156","volume":"34","author":"M. Tartaglia","year":"2003","unstructured":"Tartaglia M, Niemeyer CM, Fragale A, et al.: Somatic mutations in\n                           PTPN11\n                           in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003, 34:148\u2013150.","journal-title":"Nat Genet"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ccr.2005.01.010","volume":"7","author":"M.G. Mohi","year":"2005","unstructured":"Mohi MG, Williams IR, Dearolf CR, et al.: Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (\n                           PTPN11\n                           ) mutations. Cancer Cell 2005, 7:179\u2013191.","journal-title":"Cancer Cell"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-007-0002-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-007-0002-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-007-0002-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-007-0002-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T06:58:21Z","timestamp":1652943501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-007-0002-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s11899-007-0002-6","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"15 April 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}